| |
|
|
|
Aerpio Pharmaceuticals Inc.  
|
|
3.39 -0.31 (-0.08%) |
09-21 16:00 |
|
Open: |
3.7 |
Pre close: |
3.7 |
Target:
|
4.43 
|
|
High: |
3.934 |
Low: |
3.31 |
Resistance:
|
3.79
4.10
|
|
Volume: |
622,920 |
Market Cap: |
137M |
Support:
|
3.30
2.75
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.63
|
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
3.55 |
Signal(12,26,9): |
-0.04  |
|
MA(100): |
3.81 |
Stochastic Oscillator |
%K(14,3):
|
40.04 |
|
MA(250): |
4.59 |
%D(3): |
54.83 |
|
Average Volume(K) |
3-Month: |
8554
|
52-Week |
High:
|
6.60 |
|
10-Days: |
14887 |
Low: |
3.29 |
|
RSI |
RSI(14):
|
43.33 |
Change(%): |
-46.2 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-64.1 |
Shares Out. (M) |
40.58 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-48.9 |
Shares Float (M) |
40.58 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
33.60 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
5 |
|
Book Value (p.s.) |
2.910 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.16 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-2.03 |
P/S |
2747934208.00 |
|
Operating Margin |
-1841.86 |
Levered Free Cash Flow
(M) |
6.91 |
P/CF |
-67.77 |
|
|
|
|
|
|
